Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Pidala

Showing results (41-50 of 198) with videos related to

Pageof 20
Sort By:
JAMA Oncology|September 27, 2019
Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell TransplantationJoseph Pidala, Michael Martens, Claudio Anasetti, et al.
Transplantation and Cellular Therapy|September 25, 2025
Obesity Associations with Chronic Graft-Versus-Host DiseaseValentina Ardila, Lynn Onstad, Paul Carpenter, et al.
Plos One|March 17, 2015
Tolerance associated gene expression following allogeneic hematopoietic cell transplantationJoseph Pidala, Gregory C Bloom, Steven Eschrich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomesJoseph Pidala, Jongphil Kim, Mohamed A Kharfan-Dabaja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
Oral and Gut Microbiome Alterations in Oral Chronic GVHD Disease: Results from Close Assessment and Testing for Chronic GVHD (CATCH Study)Armin Rashidi, Joseph Pidala, Betty K Hamilton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Infliximab for managing steroid-refractory acute graft-versus-host diseaseJoseph Pidala, Jongphil Kim, Teresa Field, et al.
JAMA Dermatology|February 28, 2024
Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host DiseaseEmily Baumrin, Daniel B Shin, Nandita Mitra, et al.
Journal of Hematology & Oncology|October 8, 2010
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemiaJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Haematologica|June 21, 2011
Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease ConsortiumJoseph Pidala, Brenda F Kurland, Xiaoyu Chai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2020
Ixazomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Phase II TrialJoseph Pidala, Vijaya R Bhatt, Betty Hamilton, et al.
Pageof 20

Showing results (41-50 of 198) with videos related to

Sort By:
Pageof 20
JAMA Oncology|September 27, 2019
Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell TransplantationJoseph Pidala, Michael Martens, Claudio Anasetti, et al.
Transplantation and Cellular Therapy|September 25, 2025
Obesity Associations with Chronic Graft-Versus-Host DiseaseValentina Ardila, Lynn Onstad, Paul Carpenter, et al.
Plos One|March 17, 2015
Tolerance associated gene expression following allogeneic hematopoietic cell transplantationJoseph Pidala, Gregory C Bloom, Steven Eschrich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomesJoseph Pidala, Jongphil Kim, Mohamed A Kharfan-Dabaja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2024
Oral and Gut Microbiome Alterations in Oral Chronic GVHD Disease: Results from Close Assessment and Testing for Chronic GVHD (CATCH Study)Armin Rashidi, Joseph Pidala, Betty K Hamilton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Infliximab for managing steroid-refractory acute graft-versus-host diseaseJoseph Pidala, Jongphil Kim, Teresa Field, et al.
JAMA Dermatology|February 28, 2024
Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host DiseaseEmily Baumrin, Daniel B Shin, Nandita Mitra, et al.
Journal of Hematology & Oncology|October 8, 2010
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemiaJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Haematologica|June 21, 2011
Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease ConsortiumJoseph Pidala, Brenda F Kurland, Xiaoyu Chai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2020
Ixazomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Phase II TrialJoseph Pidala, Vijaya R Bhatt, Betty Hamilton, et al.
Pageof 20